Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thymus Neoplasms | 5 | 2022 | 268 | 0.780 |
Why?
|
Centrosome | 5 | 2004 | 201 | 0.630 |
Why?
|
Thymoma | 3 | 2022 | 186 | 0.540 |
Why?
|
Hallux | 1 | 2015 | 40 | 0.530 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2015 | 207 | 0.450 |
Why?
|
Epidural Neoplasms | 1 | 2012 | 24 | 0.430 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2020 | 1378 | 0.390 |
Why?
|
Lymphoma, AIDS-Related | 3 | 2009 | 84 | 0.370 |
Why?
|
Spinal Cord Compression | 1 | 2012 | 235 | 0.370 |
Why?
|
Leukemia | 4 | 2006 | 1511 | 0.360 |
Why?
|
Herpesvirus 4, Human | 6 | 2016 | 1041 | 0.350 |
Why?
|
Gastric Mucosa | 7 | 1989 | 599 | 0.340 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2009 | 189 | 0.330 |
Why?
|
Aneuploidy | 3 | 2003 | 530 | 0.320 |
Why?
|
Pancytopenia | 1 | 2009 | 104 | 0.320 |
Why?
|
Thoracic Vertebrae | 1 | 2012 | 608 | 0.310 |
Why?
|
Polymerase Chain Reaction | 5 | 2016 | 6171 | 0.290 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 260 | 0.290 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3920 | 0.280 |
Why?
|
Duodenal Ulcer | 7 | 1989 | 125 | 0.270 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2003 | 1519 | 0.270 |
Why?
|
Leukemic Infiltration | 1 | 2005 | 48 | 0.270 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2005 | 39 | 0.260 |
Why?
|
Herpesvirus 8, Human | 2 | 2009 | 258 | 0.250 |
Why?
|
Hodgkin Disease | 1 | 2012 | 1415 | 0.240 |
Why?
|
HIV Seropositivity | 1 | 2009 | 971 | 0.230 |
Why?
|
Blood Platelet Disorders | 1 | 2023 | 58 | 0.230 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 769 | 0.220 |
Why?
|
Ascites | 1 | 2005 | 344 | 0.220 |
Why?
|
Gene Fusion | 1 | 2006 | 371 | 0.220 |
Why?
|
Sarcoma, Myeloid | 1 | 2023 | 59 | 0.220 |
Why?
|
Fever | 2 | 2009 | 1616 | 0.210 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2005 | 2020 | 0.200 |
Why?
|
Fusion Proteins, bcr-abl | 3 | 2013 | 434 | 0.190 |
Why?
|
Chromosome Aberrations | 3 | 2018 | 1813 | 0.190 |
Why?
|
Immunohistochemistry | 9 | 2022 | 11366 | 0.190 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2020 | 1381 | 0.190 |
Why?
|
DNA, Viral | 2 | 2016 | 2225 | 0.180 |
Why?
|
Arthritis | 1 | 2005 | 659 | 0.180 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2005 | 570 | 0.170 |
Why?
|
Radioactive Pollutants | 1 | 2018 | 12 | 0.170 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2018 | 15 | 0.170 |
Why?
|
Prostaglandins E, Synthetic | 2 | 1989 | 14 | 0.170 |
Why?
|
16,16-Dimethylprostaglandin E2 | 2 | 1989 | 22 | 0.160 |
Why?
|
Papillomaviridae | 1 | 2005 | 1119 | 0.160 |
Why?
|
Thiosulfates | 2 | 1989 | 52 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2017 | 1620 | 0.160 |
Why?
|
Mitosis | 2 | 2003 | 1208 | 0.160 |
Why?
|
Histiocytosis, Sinus | 1 | 2018 | 47 | 0.160 |
Why?
|
Lymphoma, B-Cell | 3 | 2017 | 931 | 0.160 |
Why?
|
Germinal Center | 1 | 2020 | 377 | 0.160 |
Why?
|
Weight Loss | 1 | 2009 | 2622 | 0.150 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2023 | 3523 | 0.150 |
Why?
|
Stomach Ulcer | 2 | 1988 | 125 | 0.150 |
Why?
|
Cysteamine | 6 | 1989 | 23 | 0.150 |
Why?
|
Skin Neoplasms | 2 | 2015 | 5686 | 0.150 |
Why?
|
Carcinoma in Situ | 1 | 2003 | 806 | 0.150 |
Why?
|
Leydig Cells | 1 | 2016 | 56 | 0.150 |
Why?
|
Microspheres | 3 | 2005 | 777 | 0.140 |
Why?
|
Scavenger Receptors, Class B | 1 | 2016 | 81 | 0.140 |
Why?
|
Chromosome Segregation | 3 | 2003 | 235 | 0.140 |
Why?
|
Knee Joint | 1 | 2005 | 1680 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2016 | 193 | 0.140 |
Why?
|
Rectal Neoplasms | 1 | 2005 | 1206 | 0.140 |
Why?
|
Adrenal Cortex | 1 | 2016 | 140 | 0.140 |
Why?
|
Lymphoma, T-Cell | 2 | 2014 | 299 | 0.140 |
Why?
|
beta Catenin | 1 | 2021 | 1059 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2003 | 975 | 0.140 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 1 | 2014 | 12 | 0.130 |
Why?
|
B-Lymphocytes | 4 | 2020 | 4665 | 0.130 |
Why?
|
Staining and Labeling | 1 | 2019 | 1100 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2021 | 1434 | 0.130 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2017 | 1596 | 0.120 |
Why?
|
Rats, Inbred Strains | 12 | 1989 | 2186 | 0.120 |
Why?
|
Leukemia, T-Cell | 1 | 2014 | 104 | 0.120 |
Why?
|
Mediastinal Neoplasms | 1 | 2017 | 423 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 547 | 0.120 |
Why?
|
Integrin alpha Chains | 1 | 2014 | 97 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 3 | 2013 | 3772 | 0.120 |
Why?
|
Diagnosis, Differential | 7 | 2021 | 12959 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2013 | 2455 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2016 | 2942 | 0.110 |
Why?
|
Papillomavirus Infections | 1 | 2005 | 1587 | 0.110 |
Why?
|
Gastrointestinal Motility | 5 | 1989 | 225 | 0.110 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2013 | 83 | 0.110 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 606 | 0.110 |
Why?
|
Fatal Outcome | 2 | 2009 | 1850 | 0.110 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 895 | 0.110 |
Why?
|
Ovary | 1 | 2016 | 981 | 0.100 |
Why?
|
Humans | 55 | 2023 | 744343 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1832 | 0.100 |
Why?
|
Mutation | 5 | 2023 | 29786 | 0.100 |
Why?
|
Leukemia, Myeloid | 3 | 2004 | 707 | 0.100 |
Why?
|
Viral Matrix Proteins | 3 | 2016 | 186 | 0.100 |
Why?
|
Biotechnology | 2 | 2003 | 281 | 0.100 |
Why?
|
Lipid Peroxides | 2 | 1987 | 73 | 0.100 |
Why?
|
Antibodies | 1 | 2019 | 2460 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 987 | 0.100 |
Why?
|
Automation | 2 | 2003 | 584 | 0.090 |
Why?
|
Prostatic Neoplasms | 3 | 2003 | 11124 | 0.090 |
Why?
|
RNA, Messenger | 1 | 2006 | 13033 | 0.090 |
Why?
|
Neoplasms | 4 | 2016 | 21683 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 4 | 2020 | 4554 | 0.090 |
Why?
|
Peptide Initiation Factors | 2 | 2001 | 56 | 0.090 |
Why?
|
Antigens | 3 | 2001 | 1466 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 3 | 2009 | 523 | 0.090 |
Why?
|
Hypercholesterolemia | 1 | 2016 | 1151 | 0.090 |
Why?
|
Saline Solution, Hypertonic | 1 | 1989 | 110 | 0.090 |
Why?
|
Translocation, Genetic | 2 | 2006 | 1420 | 0.080 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2009 | 191 | 0.080 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5853 | 0.080 |
Why?
|
SRS-A | 1 | 1988 | 156 | 0.080 |
Why?
|
Molecular Biology | 2 | 2022 | 596 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 2 | 2003 | 738 | 0.080 |
Why?
|
Bone Marrow | 3 | 2023 | 2948 | 0.080 |
Why?
|
Biopsy, Fine-Needle | 1 | 2013 | 1094 | 0.080 |
Why?
|
Male | 26 | 2022 | 350118 | 0.080 |
Why?
|
Free Radicals | 1 | 1987 | 237 | 0.080 |
Why?
|
Catalase | 1 | 1987 | 222 | 0.070 |
Why?
|
Ethanol | 4 | 1988 | 1342 | 0.070 |
Why?
|
Duodenum | 4 | 1989 | 483 | 0.070 |
Why?
|
Hematopoiesis, Extramedullary | 2 | 2016 | 60 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 990 | 0.070 |
Why?
|
Female | 33 | 2022 | 380194 | 0.070 |
Why?
|
Gene Dosage | 2 | 2018 | 1252 | 0.070 |
Why?
|
Antigens, CD | 2 | 2014 | 4026 | 0.070 |
Why?
|
Dyspnea | 1 | 2014 | 1303 | 0.070 |
Why?
|
alpha-Thalassemia | 1 | 2006 | 46 | 0.070 |
Why?
|
Purines | 1 | 2009 | 594 | 0.070 |
Why?
|
Plasma Cells | 1 | 2009 | 591 | 0.070 |
Why?
|
Middle Aged | 16 | 2022 | 213383 | 0.060 |
Why?
|
Pancreatic Juice | 1 | 1985 | 62 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 1987 | 597 | 0.060 |
Why?
|
Bile | 2 | 1985 | 299 | 0.060 |
Why?
|
Acute Disease | 4 | 2009 | 7149 | 0.060 |
Why?
|
Multiple Myeloma | 2 | 2013 | 5181 | 0.060 |
Why?
|
Hydrochloric Acid | 4 | 1988 | 76 | 0.060 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2005 | 97 | 0.060 |
Why?
|
Animals | 28 | 2023 | 168757 | 0.060 |
Why?
|
Mycoplasma Infections | 1 | 2004 | 118 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 1 | 2006 | 1375 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6103 | 0.060 |
Why?
|
Nitriles | 3 | 1987 | 956 | 0.060 |
Why?
|
Sarcoma, Experimental | 1 | 2003 | 128 | 0.060 |
Why?
|
Point Mutation | 3 | 2006 | 1623 | 0.060 |
Why?
|
Tumor Virus Infections | 2 | 1997 | 452 | 0.060 |
Why?
|
Lung Diseases | 1 | 2014 | 1886 | 0.060 |
Why?
|
Signal Transduction | 5 | 2016 | 23403 | 0.060 |
Why?
|
Synovial Fluid | 1 | 2005 | 394 | 0.060 |
Why?
|
Antioxidants | 2 | 1989 | 1663 | 0.060 |
Why?
|
Chromosome Breakage | 1 | 2003 | 173 | 0.060 |
Why?
|
Immunoblotting | 2 | 2016 | 1682 | 0.050 |
Why?
|
Rats | 14 | 1989 | 24260 | 0.050 |
Why?
|
Aged | 11 | 2022 | 163280 | 0.050 |
Why?
|
DNA | 3 | 2023 | 7301 | 0.050 |
Why?
|
Mice | 13 | 2023 | 81183 | 0.050 |
Why?
|
DNA Probes | 1 | 2003 | 560 | 0.050 |
Why?
|
Adult | 14 | 2022 | 214055 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6895 | 0.050 |
Why?
|
Microcirculation | 1 | 1986 | 1286 | 0.050 |
Why?
|
Immunoenzyme Techniques | 3 | 2001 | 1799 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2016 | 2948 | 0.050 |
Why?
|
E2F6 Transcription Factor | 1 | 2021 | 2 | 0.050 |
Why?
|
Cell Division | 3 | 2004 | 4568 | 0.050 |
Why?
|
Eukaryotic Initiation Factor-2 | 2 | 2001 | 190 | 0.050 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 345 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2005 | 1588 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2022 | 57776 | 0.050 |
Why?
|
Cyclins | 1 | 2004 | 603 | 0.050 |
Why?
|
Gene Amplification | 1 | 2006 | 1063 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2020 | 9648 | 0.050 |
Why?
|
Liver | 2 | 2016 | 7474 | 0.050 |
Why?
|
Racemases and Epimerases | 1 | 2001 | 113 | 0.050 |
Why?
|
Lymphoma | 1 | 1990 | 1877 | 0.050 |
Why?
|
Survival Rate | 4 | 2017 | 12788 | 0.050 |
Why?
|
Loss of Heterozygosity | 2 | 2018 | 684 | 0.050 |
Why?
|
Scleroderma, Systemic | 1 | 2004 | 323 | 0.050 |
Why?
|
Pancreatitis | 1 | 2007 | 1092 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2003 | 5391 | 0.050 |
Why?
|
DNA, Neoplasm | 1 | 2006 | 1758 | 0.050 |
Why?
|
DNA Helicases | 1 | 2006 | 859 | 0.050 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 212 | 0.040 |
Why?
|
Splenomegaly | 2 | 2016 | 190 | 0.040 |
Why?
|
Epirizole | 2 | 1989 | 3 | 0.040 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2003 | 387 | 0.040 |
Why?
|
Sodium Hydroxide | 3 | 1987 | 44 | 0.040 |
Why?
|
HIV Infections | 1 | 2005 | 16718 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 644 | 0.040 |
Why?
|
Gastric Acid | 4 | 1987 | 104 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2022 | 491 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 316 | 0.040 |
Why?
|
Intestine, Small | 2 | 2004 | 1241 | 0.040 |
Why?
|
Ukraine | 1 | 2018 | 111 | 0.040 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2019 | 136 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4751 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2003 | 1117 | 0.040 |
Why?
|
Transplantation, Heterologous | 3 | 2016 | 2382 | 0.040 |
Why?
|
Hypohidrosis | 1 | 1998 | 29 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14722 | 0.040 |
Why?
|
Biopsy, Needle | 3 | 2007 | 1641 | 0.040 |
Why?
|
Calreticulin | 1 | 2018 | 98 | 0.040 |
Why?
|
Herpesviridae Infections | 2 | 1997 | 277 | 0.040 |
Why?
|
Splenic Rupture | 1 | 1997 | 26 | 0.040 |
Why?
|
Immunotoxins | 2 | 1997 | 179 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2018 | 157 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1866 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1285 | 0.040 |
Why?
|
Prognosis | 3 | 2023 | 29063 | 0.040 |
Why?
|
Leukocytes | 1 | 2005 | 2043 | 0.040 |
Why?
|
Reticulocytosis | 1 | 2016 | 10 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2023 | 1782 | 0.040 |
Why?
|
Anemia, Macrocytic | 1 | 2016 | 55 | 0.040 |
Why?
|
Receptors, Lipoprotein | 1 | 2016 | 81 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2009 | 2957 | 0.040 |
Why?
|
Cadherins | 1 | 2021 | 907 | 0.040 |
Why?
|
Sweat Gland Neoplasms | 1 | 1998 | 108 | 0.030 |
Why?
|
Celiac Disease | 1 | 2004 | 785 | 0.030 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 118 | 0.030 |
Why?
|
Sjogren's Syndrome | 1 | 1998 | 233 | 0.030 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 1996 | 48 | 0.030 |
Why?
|
Autoantibodies | 1 | 2004 | 2035 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 631 | 0.030 |
Why?
|
Myelodysplastic Syndromes | 1 | 2006 | 1352 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1788 | 0.030 |
Why?
|
Thrombocytosis | 1 | 1996 | 81 | 0.030 |
Why?
|
Aspirin | 1 | 1987 | 3282 | 0.030 |
Why?
|
Forearm | 1 | 2018 | 409 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2007 | 2133 | 0.030 |
Why?
|
Microscopy, Fluorescence | 2 | 2019 | 2699 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2003 | 20822 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 528 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2012 | 18111 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2016 | 418 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2002 | 1526 | 0.030 |
Why?
|
Equipment Design | 1 | 2003 | 3582 | 0.030 |
Why?
|
Blood Donors | 1 | 1997 | 355 | 0.030 |
Why?
|
Pruritus | 1 | 1998 | 361 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 1996 | 565 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 1998 | 477 | 0.030 |
Why?
|
Phytohemagglutinins | 1 | 1994 | 170 | 0.030 |
Why?
|
NF-kappa B | 2 | 2009 | 2499 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1997 | 648 | 0.030 |
Why?
|
Frozen Sections | 1 | 2014 | 155 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 2505 | 0.030 |
Why?
|
Lymphocytes | 1 | 2022 | 2617 | 0.030 |
Why?
|
Alopecia | 1 | 1998 | 382 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3271 | 0.030 |
Why?
|
Cell Line | 3 | 2019 | 15997 | 0.030 |
Why?
|
Base Sequence | 4 | 2012 | 12797 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2014 | 299 | 0.030 |
Why?
|
Primary Myelofibrosis | 1 | 1996 | 215 | 0.030 |
Why?
|
Coronary Occlusion | 1 | 2016 | 304 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2649 | 0.030 |
Why?
|
Diphtheria Toxin | 1 | 1994 | 255 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 56430 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5535 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 1998 | 6314 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2012 | 103 | 0.030 |
Why?
|
Receptors, Interleukin-2 | 1 | 1994 | 573 | 0.030 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 74 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3462 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 638 | 0.030 |
Why?
|
Stem Cells | 1 | 2005 | 3567 | 0.030 |
Why?
|
Cell Survival | 1 | 2002 | 5882 | 0.030 |
Why?
|
NIH 3T3 Cells | 2 | 2004 | 677 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1950 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 873 | 0.030 |
Why?
|
Risk Assessment | 2 | 2003 | 23338 | 0.030 |
Why?
|
Pyridines | 3 | 1989 | 2825 | 0.030 |
Why?
|
Immunologic Factors | 2 | 2007 | 1580 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1878 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10180 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2124 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2019 | 1917 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 1989 | 1130 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 4386 | 0.020 |
Why?
|
Thorax | 1 | 2014 | 547 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2016 | 1438 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2716 | 0.020 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 1 | 1990 | 20 | 0.020 |
Why?
|
Sodium Radioisotopes | 1 | 1989 | 6 | 0.020 |
Why?
|
Parvoviridae Infections | 1 | 1990 | 35 | 0.020 |
Why?
|
Genotype | 1 | 2005 | 12951 | 0.020 |
Why?
|
Blood Platelets | 1 | 2001 | 2508 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 905 | 0.020 |
Why?
|
Carcinoma | 1 | 2001 | 2375 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1998 | 2232 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-4E | 2 | 2001 | 107 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2564 | 0.020 |
Why?
|
Gastric Emptying | 2 | 1988 | 233 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2715 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2009 | 180 | 0.020 |
Why?
|
Phenotype | 2 | 2001 | 16365 | 0.020 |
Why?
|
Bicarbonates | 2 | 1987 | 313 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1678 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2016 | 1179 | 0.020 |
Why?
|
Phenothiazines | 1 | 1988 | 63 | 0.020 |
Why?
|
Time Factors | 4 | 2003 | 40075 | 0.020 |
Why?
|
Retina | 1 | 2019 | 2616 | 0.020 |
Why?
|
Pyrazoles | 2 | 1989 | 1972 | 0.020 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1988 | 94 | 0.020 |
Why?
|
Antibodies, Monoclonal | 3 | 2014 | 9274 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1265 | 0.020 |
Why?
|
Tissue Donors | 1 | 1997 | 2240 | 0.020 |
Why?
|
Transcription Factors | 2 | 2004 | 12208 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2889 | 0.020 |
Why?
|
Capillary Permeability | 2 | 1988 | 798 | 0.020 |
Why?
|
Apoptosis | 2 | 2003 | 9727 | 0.020 |
Why?
|
Cell Cycle | 2 | 2009 | 2967 | 0.020 |
Why?
|
Burkitt Lymphoma | 1 | 2009 | 327 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1994 | 1904 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3505 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77449 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2003 | 5974 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1157 | 0.020 |
Why?
|
Regional Blood Flow | 2 | 1986 | 1525 | 0.020 |
Why?
|
Child | 3 | 2003 | 77709 | 0.020 |
Why?
|
Rheology | 1 | 1986 | 345 | 0.020 |
Why?
|
Ethanolamine | 1 | 1985 | 3 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2016 | 11483 | 0.020 |
Why?
|
Taurocholic Acid | 1 | 1985 | 43 | 0.020 |
Why?
|
Stomach Diseases | 1 | 1986 | 134 | 0.020 |
Why?
|
Gastric Juice | 1 | 1985 | 63 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 19229 | 0.020 |
Why?
|
Mucus | 1 | 1987 | 321 | 0.020 |
Why?
|
Pyloric Antrum | 1 | 1985 | 69 | 0.020 |
Why?
|
Pepsin A | 1 | 1985 | 71 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2003 | 19905 | 0.020 |
Why?
|
Common Bile Duct | 1 | 1985 | 109 | 0.020 |
Why?
|
Ultrasonography | 1 | 2018 | 5985 | 0.020 |
Why?
|
Pylorus | 1 | 1985 | 86 | 0.020 |
Why?
|
Ethanolamines | 1 | 1985 | 158 | 0.020 |
Why?
|
Artificial Gene Fusion | 1 | 2004 | 57 | 0.020 |
Why?
|
Intestinal Secretions | 1 | 1984 | 15 | 0.020 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2004 | 45 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 693 | 0.020 |
Why?
|
Mycoplasma | 1 | 2004 | 139 | 0.020 |
Why?
|
Disease Progression | 1 | 2001 | 13284 | 0.010 |
Why?
|
Ligation | 1 | 1985 | 453 | 0.010 |
Why?
|
Transcription Factor AP-2 | 1 | 2004 | 82 | 0.010 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 3 | 1989 | 96 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2016 | 3690 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
Mice, Inbred C57BL | 3 | 2009 | 21827 | 0.010 |
Why?
|
Hematopoietic System | 1 | 2003 | 109 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.010 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2004 | 164 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2004 | 803 | 0.010 |
Why?
|
Capillaries | 1 | 1986 | 773 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2004 | 277 | 0.010 |
Why?
|
Interleukin-7 | 1 | 2003 | 142 | 0.010 |
Why?
|
Acetylcholine | 1 | 1985 | 621 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 365 | 0.010 |
Why?
|
Prednisone | 1 | 2007 | 1574 | 0.010 |
Why?
|
Electrodes | 1 | 1985 | 619 | 0.010 |
Why?
|
Blotting, Western | 2 | 2001 | 5179 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2002 | 77 | 0.010 |
Why?
|
Models, Animal | 1 | 2009 | 2171 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1997 | 4251 | 0.010 |
Why?
|
Sequence Deletion | 2 | 1997 | 1526 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1990 | 2513 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6756 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 2003 | 455 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2003 | 463 | 0.010 |
Why?
|
Coronary Disease | 1 | 2016 | 6077 | 0.010 |
Why?
|
Cytochalasin B | 1 | 2001 | 74 | 0.010 |
Why?
|
Retroviridae | 1 | 2004 | 914 | 0.010 |
Why?
|
Sulfur Radioisotopes | 1 | 2001 | 116 | 0.010 |
Why?
|
Nocodazole | 1 | 2001 | 97 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2003 | 380 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4803 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2001 | 192 | 0.010 |
Why?
|
Detergents | 1 | 2001 | 230 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 452 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 2003 | 9734 | 0.010 |
Why?
|
Dyneins | 1 | 2001 | 123 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 40561 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39050 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 2050 | 0.010 |
Why?
|
Keratins | 1 | 2001 | 515 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2001 | 829 | 0.010 |
Why?
|
Autoantigens | 1 | 2004 | 892 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 1998 | 8863 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1985 | 1240 | 0.010 |
Why?
|
Electromyography | 1 | 1985 | 1379 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2437 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 2001 | 425 | 0.010 |
Why?
|
Wnt Proteins | 1 | 2003 | 721 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 2892 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2255 | 0.010 |
Why?
|
Proteomics | 1 | 2012 | 3638 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2839 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 1997 | 5442 | 0.010 |
Why?
|
Fasting | 1 | 1985 | 1593 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15076 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2003 | 13815 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2007 | 2107 | 0.010 |
Why?
|
CHO Cells | 1 | 2001 | 1406 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 853 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1701 | 0.010 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2004 | 868 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4420 | 0.010 |
Why?
|
Platelet Aggregation | 1 | 2001 | 798 | 0.010 |
Why?
|
Hemoperitoneum | 1 | 1997 | 40 | 0.010 |
Why?
|
Glomerulonephritis, IGA | 1 | 1997 | 66 | 0.010 |
Why?
|
Leukapheresis | 1 | 1997 | 131 | 0.010 |
Why?
|
Cricetinae | 1 | 2001 | 2472 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 1987 | 18029 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6487 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 1997 | 354 | 0.010 |
Why?
|
Autoimmunity | 1 | 2004 | 1349 | 0.010 |
Why?
|
Cytoplasm | 1 | 2001 | 1539 | 0.010 |
Why?
|
Intestinal Mucosa | 2 | 2004 | 3036 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1985 | 10943 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16689 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11524 | 0.010 |
Why?
|
Splenectomy | 1 | 1997 | 395 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5892 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2001 | 1086 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6386 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1997 | 15295 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2088 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1987 | 2624 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 1996 | 211 | 0.010 |
Why?
|
Virus Latency | 1 | 1997 | 358 | 0.010 |
Why?
|
Microtubules | 1 | 2001 | 1090 | 0.010 |
Why?
|
Half-Life | 1 | 1996 | 661 | 0.010 |
Why?
|
Hemorrhage | 1 | 1986 | 3461 | 0.010 |
Why?
|
Amino Acids | 1 | 2001 | 1736 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2004 | 1861 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 85781 | 0.010 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1996 | 442 | 0.010 |
Why?
|
Pneumothorax | 1 | 1997 | 379 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2126 | 0.010 |
Why?
|
Prostate | 1 | 2001 | 1774 | 0.010 |
Why?
|
Fibroblasts | 1 | 2004 | 4161 | 0.010 |
Why?
|
Living Donors | 1 | 1997 | 620 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1997 | 1791 | 0.010 |
Why?
|
Collagen | 1 | 2001 | 2689 | 0.010 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1997 | 689 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 4982 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1996 | 2256 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1996 | 1880 | 0.010 |
Why?
|
Selection, Genetic | 1 | 1996 | 914 | 0.010 |
Why?
|
Parvoviridae | 1 | 1990 | 7 | 0.010 |
Why?
|
Calcium | 1 | 2003 | 5756 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 1997 | 2765 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1996 | 3846 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 1997 | 4776 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2003 | 14557 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2004 | 20129 | 0.010 |
Why?
|
Pancreas | 2 | 1985 | 1686 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1999 | 3474 | 0.000 |
Why?
|
Benzene Derivatives | 1 | 1987 | 54 | 0.000 |
Why?
|
Malondialdehyde | 1 | 1987 | 105 | 0.000 |
Why?
|
Injections, Subcutaneous | 1 | 1988 | 666 | 0.000 |
Why?
|
United States | 1 | 2014 | 69872 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15540 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7181 | 0.000 |
Why?
|
Ergolines | 1 | 1985 | 61 | 0.000 |
Why?
|
Bromocriptine | 1 | 1985 | 111 | 0.000 |
Why?
|
Amylases | 1 | 1985 | 173 | 0.000 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1985 | 158 | 0.000 |
Why?
|
Recurrence | 1 | 1997 | 8340 | 0.000 |
Why?
|
Trypsin | 1 | 1985 | 511 | 0.000 |
Why?
|
Prostaglandins | 1 | 1986 | 405 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9583 | 0.000 |
Why?
|
Spleen | 1 | 1990 | 2362 | 0.000 |
Why?
|
Genetic Variation | 1 | 1997 | 6544 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1994 | 5097 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2007 | 63114 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1988 | 4933 | 0.000 |
Why?
|
Electrodes, Implanted | 1 | 1984 | 824 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1990 | 3176 | 0.000 |
Why?
|
Ischemia | 1 | 1987 | 1907 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 13695 | 0.000 |
Why?
|
Chronic Disease | 1 | 1988 | 9146 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1998 | 35421 | 0.000 |
Why?
|